Introduction
Spinocerebellar ataxia type 7 (SCA7) is one of nine polyglutamine (polyQ) diseases, a group of inherited neurodegenerative disorders including Huntington's disease, spinal and bulbar muscular atrophy (SBMA)/Kennedy s disease, spinocerebellar ataxia types 1, 2, 3, 6, 7, & 17, and dentato-rubro-pallido-luysian atrophy (DRPLA) [1, 2] . Cerebellar ataxia and progressive retinal degeneration attributed to neuronal loss of Purkinje cells in the cerebellum and drop-out of cone-photoreceptor cells in the retina are characteristic symptoms of SCA7 [3] . The polyQ tract sequence is located at the N-terminal region of the causative gene product, ATXN7 protein. Normal 4 For the transcription function, nuclear localization of ATXN7 is essential. However, partial or transient cytoplasmic localization of ATXN7 was reported in vivo and in vitro.
First, cytoplasmic localization of ATXN7 was observed in patient and control brains [14] [15] [16] . Second, ATXN7 possesses a nuclear export signal sequence (NES) in addition to nuclear localization sequence (NLS), and it shuttles between nucleus and cytoplasm [17] , like another SCA protein [18] . Beside the simple explanation that the transcriptional function can be switched off by the nuclear export, these findings suggest that ATXN7 may perform certain cytoplasmic functions.
Here, we report that cytoplasmic ATXN7 has microtubule associating and stabilizing properties. Association with microtubules was observed for both normal and mutant ATXN7, just as previous work found that normal and mutant ATXN7 can both regulate transcription [19] . As altered ATXN7 function in the SCA7 brain is likely important for disease pathogenesis, our discovery of a novel cytoplasmic function for ATXN7 may provide another mechanism for SCA7 disease pathology.
Results

ATXN7 distribution dynamically changes in nucleus and cytoplasm
It is essential to use cell lines expressing ATXN7 endogenously to address the physiological function of ATXN7. We thus selected HeLa cells, as HeLa cells are known to express ATXN7 endogenously [19] . Localization of normal and mutant ATXN7 was analyzed by expressing fusion proteins of DsRED and normal (10Q) or mutant (92Q) full-length ATXN7 in HeLa cells. As reported previously [17] , live-imaging analysis with transfected HeLa cells revealed that ATXN7 protein exists both in the nucleus and cytoplasm, and its expression levels and nuclear to by guest on http://hmg.oxfordjournals.org/ Downloaded from 5 cytoplasmic ratio change dynamically during the cell cycle or morphological transformation ( Suppl Fig 1 and Movies). To our surprise, the intra-cytoplasmic distribution of ATXN7 also changed. We noticed that both normal (10Q) and mutant (92Q) ATXN7 transiently showed filamentous structures in the cytoplasm, which is reminiscent of the microtubule (MT) network ( Suppl Fig 1 and Movies) .
Cytoplasmic distribution of endogenous ATXN7 during cell cycle
To further address ATXN7 cytoplasmic distribution and possible co-localization with microtubules (MTs), we performed immunocytochemistry of non-transfected HeLa cells (Fig 1) . The specific antibody revealed various types of ATXN7 distribution that could be aligned in an order suggested by the information from live imaging. In a large proportion of cells, ATXN7 showed predominant nuclear distribution, and decreased cytoplasmic staining (Supplementary Figure 1) . However, before going into M phase, HeLa cells at late G2 phase showed an increase in the concentration of cytoplasmic ATXN7 protein at the perinuclear region. The perinuclear foci did not merge initially with centrosomes in most cases (Fig 1) . However, when mitosis started, ATXN7 began to merge with -tubulin, overlapped with the spindle, but distributed in a wider area (Fig 1) . When mitosis ended, ATXN7 separated from the spindle (Fig 1) , and redistributed to the nucleus (Fig 1) . However, even after mitosis, a small amount of ATXN7 remained in the cytoplasm at the perinuclear region and displayed fibrillar patterns in the cytoplasm (Fig 1) . During mitosis, ATXN7 did not stably overlap with actin (data not shown). 
ATXN7 associates with microtubules
To directly test interaction between ATXN7 and MTs, myc-ATXN7-10Q or 92Q transfected cells were double-immunostained with anti-Myc and anti-α-tubulin antibodies. The transfected myc-ATXN7 enabled us to analyze the low level of cytoplasmic ATXN7 and revealed co-localization of the two proteins in a filamentous reticular structure after mitosis (Fig 2A) . Staining patterns of neighboring cells clearly excluded detection of α-tubulin signals though the green filter. Interestingly, both normal and abnormal ATXN7 showed similar reticular patterns in the cytoplasm (Fig   2A) . As observed in live-imaging, a fraction of transfected HeLa cells showed nuclear-restricted localization of ATXN7 (Fig 2A) .
To examine physical interaction between ATXN7 and α-tubulin, cell lysates from the transfected HeLa cells were subjected to immunoprecipitation with anti-Myc antibody.
Ataxin-1 with Myc-tag (Myc-ATXN1) was also used to test the specificity of interaction between ATXN7 and α-tubulin. As expected, Myc-ATXN7 -but not Myc-ATXN1 -co-precipitated α-tubulin (Fig 2B) . Conversely, immunoprecipitation by anti-α-tubulin antibody co-precipitated Myc-ATXN7, but not Myc-ATXN1 (Fig 2C) . These results supported a specific association between ATXN7 and α-tubulin/MTs in HeLa cells. No remarkable difference was observed in the amount of co-precipitated α-tubulin between normal (10Q) and mutant (92Q) ATXN7. In order to exclude non-specific interaction of anti-Myc antibody to MTs, 1C2 antibody, that detects expanded polyQ tracts, was also used for immunocytochemistry. Filamentous structures derived from mutant ATXN7 were still observed (data not shown). 
Defining the ATXN7 domain necessary for microtubule interaction
To determine the ATXN7 domain responsible for association with MTs, a series of deletion constructs was generated (Fig 3A) , and tested for their localization and binding to α-tubulin. In immunocytochemistry with anti-Myc and anti-α-tubulin antibodies, AA1-850 and AA1-614 showed the typical filamentous pattern (Fig 3B) .
AA120-400 and AA120-620 also distributed in the filamentous pattern, frequently.
The filamentous pattern was sometimes seen with the AA1-230 construct, but not found in the other deletion constructs (Fig 3B) .
Immunoprecipitation results supported interaction of AA1-850 and AA1-614 with α-tubulin, and AA120-400 and AA1-230 constructs also showed association with α-tubulin (Fig 4A, B) . Again, a weak association of AA1-230 with α-tubulin was observed. These results consistently suggested that the amino acid residues from 120 to 400 (AA120-400) mediate association of ATXN7 with α-tubulin, and AA120-230 appear most important within this region. However, the strongest interaction was observed with the full-length ATXN7, suggesting that ATXN7 uses multiple regions for association with α-tubulin. A short fragment (AA1-65) including polyQ tract sequence was prone to aggregate (Fig 4B) , whereas it did not interact with α-tubulin. The AA1-65 fragment also showed a number of small dots in immunocytochemistry (Fig 3B) , while it did not form a single large inclusion body corresponding to the aggresome/centrosome. [21] , amino acids that are highly represented within the evolutionally conserved domains of ATXN7. Furthermore, informatics analysis by MOTIF Search (URL: http://www.genome.jp/tools/motif/) identified a tau signature [22] at AA429-437 (mouse ATXN7) and AA450-458 (human ATXN7), as well as a homologous sequence to Doublecortin, a microtubule-associated protein that stabilizes MTs [23, 24] at AA687-715 (mouse ATXN7). These observations support direct binding of ATXN7 to MTs. When we compared the binding affinity of -tubulin to normal (10Q) and mutant (92Q) ATXN7, we did not observe any obvious differences ( Figure 4A , B)
indicating that the interaction does not depend on the polyQ domain or its repeat length.
ATXN7 contributes to microtubule stabilization
Normally, microtubules radiate from the MT formation center [25] . However, as shown in Figure 2C -F), some of the ATXN7-transfected cells exhibited thicker, meandering microtubules rather than the normal radiating form. This is known to represent an over-stabilized form of MTs [26] , leading us to hypothesize that this result may arise from a microtubule-stabilizing effect of ATXN7. To test whether ATXN7 stabilizes MTs, we treated cells with nocodazole, a well-known inhibitor of MT polymerization [27] ( Fig 5A) . Normal (10Q) or mutant (92Q) ATXN7-transfected cells were treated with 10 nM nocodazole for 5, 10 or 30 minutes (Fig 5B, C) . Even after 30 minutes treatment, the MT distribution was maintained filamentous by co-expression of ATXN7, while the filamentous pattern of MTs rapidly disappeared in untransfected cells (Fig 5A) . The stabilization effects were similar in cells expressing normal (10Q) and mutant (92Q) 9 ATXN7 (Fig4D). We also tried to monitor MT stabilization by ATXN7 with live cell imaging, whereas the signal of newly generated -tubulin-EGFP was homogenous rather than filamentous in the cytoplasm and not suitable for the analysis.
Further to test the effect of ATXN7 on MTs stabilization, we knocked down ATXN7 with a validated siRNA (Fig 6A) . The filamentous MT network disappeared faster in siRNA-transfected cells in the presence of nocodazole (Fig 6B) . The recovery of the MT network after removal of nocodazole was also delayed. These findings support the conclusion that ATXN7 stabilizes MTs. Decreased expression of ATXN7 in siRNA-transfected cells was confirmed by western blot (Suppl Fig 2) .
Discussion
In this study, we report dramatic co-localization of ATXN7 and MTs, biochemical interaction between ATXN7 and α-tubulin, and a functional role for ATXN7 in MT A major concern for our observation is that over-expressed ATXN7 might be carried on the rail of MTs to aggresomes to form inclusion bodies as part of the cell's effort to sequester a misfolded, polyQ rich protein [28] . However, dynamic changes of ATXN7 in the nucleus and cytoplasm indicated that the association with MTs is neither aggregation nor protein degradation-related accumulation. The cytoplasmic distribution was also highly variable, assuming various patterns, suggesting that the association is not to promote protein degradation or sequestration. Moreover, immunocytochemistry of endogenous ATXN7 showed a similar reticular pattern, excluding the possibility that the cytoplasmic distribution of ATXN7 was an artifact of over-expression.
Interactome studies of ATXN7 based on the yeast two-hybrid technique revealed that ATXN7 and the macular degeneration disease proteins EFEMP1 and FBLN5 share a molecular network sub-domain within the protein-protein interaction network [20] .
However, these interactome databases do not include -or -tubulin in the ATXN7 protein interaction network. This is also the case with the String database at EMBL.
As the formation of reticular patterns in the cytoplasm by ATXN7 depends upon cell cycle stage and is therefore transient, the interaction between ATXN7 and α-tubulin may not be detectable with a transcription-based interaction assay in yeast cells.
Since the deletion analysis of ATXN7 did not narrow down the interacting region to a short motif, it is also possible that ATXN7 might utilize multiple co-factors for an indirect association with MTs. In addition to not predicting an interaction between ATXN7 and MTs, the ATXN7 interactome database lists several forms of actin as candidate interactors [20] . Despite this prediction, our live imaging of HeLa cells expressing actin-GFP and ATXN7-DsRed did not yield any evidence for an actin -ATXN7 interaction. The actin distribution at the cell periphery did not merge with the ATXN7 meshwork (Supplementary Figure 3A) , and immunoprecipiation did not support strong or stable interaction between ATXN7 and -actin (Supplementary Figure 3B) . Cytochalasin B treatment for 30 minutes disrupted atcin-network but did not affect ATXN7 meshwork in Hela cells (Supplementary Figure 4) . Nevertheless, actin may still mediate interaction between MT and ATXN7 in neurons.
Actin fibers and MTs form independent cytoskeletal networks of different diameters and different distribution in cells. The two networks engage in crosstalk during diverse cellular processes including cell motility, neuronal path finding, cellular wound healing, cell division and cortical flow [29] . This dynamic, spatiotemporal crosstalk is especially critical for neurons in growth cone formation and neurite branching. Figure 7) . However, the molecular basis of the interaction between actin fibers and MT networks is not fully understood, except for some cases including ShortStop (Shot), the Drosophila spectraplakin protein that mediates interaction between these two cytoskeletal networks [30] . Moreover, the distribution of ATXN7 observed in Hela cells was clearly distinct from that of actin fibers, arguing against interactions between actin and ATXN7 in the context of MTs. Collectively, the role of actin in ATXN7-MT association needs further investigation.
Stability of MTs is crucial for neurons to maintain the cell body architecture and consistent neurite structures. PolyQ-expanded ATXN7 has been shown to be present in the nucleus and there interfere with the function of the STAGA HAT complex, leading to transcriptional dysregulation of photoreceptor genes in the retina [19, 31, 32] . Although ATXN7 has a well-described function in the nucleus, it is clear that proteins can perform multiple functions in various cellular compartments. Indeed, the polyQ disease protein huntingtin has been shown to play a role in axonal transport and vesicle-mediated transport in endocytosis [33] [34] [35] , while at the same time, upon proteolytic cleavage an amino-terminal fragment of the huntingtin protein has been shown to be a transcription factor in the TFIID and TFIIF co-activator complexes [36] . Hence, a nuclear function for ATXN7 does not exclude a possible independent role for it in the cytosol. If ATXN7 is interacting with MTs in the cytosol, an important question is whether this interaction might be altered upon polyQ expansion in SCA7 disease. Our results indicate that glutamine tract length does not affect ATXN7 interaction with MTs or its ability to modulate the MT network.
Nonetheless, polyQ-expanded ATXN7 in the context of neurons could engage in inappropriate or altered interactions with co-factors whose dysregulation might affect intracellular protein trafficking, organelle delivery, or axonal transport pathways. It thus remains to be seen if mutant ATXN7 might reduce the accessibility of normal ATXN7 or some other factor to MTs, and might impair ATXN7 functions in stabilization of MTs and/or cross-talk between MT and actin networks. Another aspect of ATXN7 biology to consider is that ATXN7 is cleaved at AA256 and AA344 by caspase-7 [37] . Our Western blot analysis of Myc-ATXN7-10Q or -92Q expressing cells with a specific anti-Myc antibody detected multiple bands of ATXN7 (Fig 2C) , suggesting that ATXN7 is cleaved at multiple sites. Importantly, the short 
Materials and Methods
Plasmid construction
The pCMV-myc-ataxin7-10Q and 92Q plasmids were generated as described previously [38] . Human ATXN7-10Q and 92Q cDNA were amplified by PCR using 5 -TCATAAGCTTCGATGTCGGAGCGGGCCGCG-3 (AT7-HindIII-F) 5 -TCATGTCGACTCAGGGACGTGCCTTTGGCT-3' (ATXN7-SalI-R) primers from pCMV-myc-ATXN7-10Q and 92Q [34] , respectively. The PCR products were 
Western blot
Anti-Myc (SIGMA, 9E10) and anti-α-tubulin (SIGMA) primary antibodies were used at 1:1000. HRP conjugated anti-mouse IgG (Amersham) were used at 1:3000. ECL (GE Healthcare) was used to detect bands following the commercial protocol.
Immunoprecipitation
HeLa cells plated in 6-well plate were transfected by Lipofectamin 2000 (Invitrogen) and incubated for 36h. The cells were lysed in 250 μl TNE buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 5 mM EDTA, 0.25% Nonidet P-40) was added. After removing debris by centrifugation, cell lysates were incubated for 2 hours at 4°C with 20 μl of protein G-agarose beads (GE Healthcare, 50% v/v) to remove non-specific binding proteins. After centrifugation, the sup was incubated with 2 μg of anti-Myc (SIGMA, 9E10) or anti -tubulin antibody overnight at 4 °C, followed by incubation with agarose beads for 2 h at 4 °C. The beads were precipitated and washed five times with TNE buffer. Bound proteins were resolved by SDS-PAGE, followed by Western blotting with the indicated antibodies.
Nocodazole treatment and MT stabilization assay
This assay was performed basically following the method by Hergovich et al. [39] . In brief, HeLa cells plated on glass cover lips were transfected with myc-AT7-10Q/92Q
and incubated for 36hours. Then, nocodazole (Sigma Aldrich) was solved in DMSO and added to the culture medium (final concentration 10nM). Hela cells were cultured additionally for indicated time at 37°C and stained as described above. Cells possessing MT network were counted 3 times for each condition.
siRNA knock down of endogenous ATXN7
Pre-designated small interfering RNA (siRNA) for human SCA7 was purchased from QIAGEN (catalogue number 1027416). From four different siRNAs, Hs-ATXN7-1 (SI00308273) was selected for our experiments. The sense sequence of Hs-ATXN7-1 and control siRNA (Qiagen) were 5 -CACCCGGTCTTTGACATGCAA-3 and 5'-UUCUCCGAACGUGUCACGUdTdT-3', respectively. The siRNAs were transfected into HeLa cells using Lipofectamine2000 
Immunohistochemistry of normal young mice
Fresh brains of C57BL/6 mice at 4 weeks were fixed in phosphate-buffered 4% paraformaldehyde and embedded in paraffin. Sections (5 or 10 μm-thick) were dewaxed in xylene and rehydrated using a descending ethanol series. Sections were boiled in 0.01M citrate buffer, pH 6.0, in a microwave oven three times and kept in room temperature for 30 minutes after final boil. Incubation in PBS with 1% bovine serum albumin and 0.01% (v/v) Triton X-100 was performed for 30 min in order to block nonspecific binding. Sections were incubated overnight at 4Cº with primary antibody, followed by incubation with secondary antibodies for 1-2 h at room 
Immunohistochemistry of ATXN7 transgenic mice
Generation of human ATXN7-92Q transgenic mouse was reported previously [40] . (Jackson, rabbit, 1:500,).
Lentiviral vector: DsRED-ATXN7
Human ATXN7-10Q and 92Q cDNA were amplified by PCR using 
Rat brain primary culture and infection of lenti-virus
Briefly, cerebral cortexes from 18 day-old Wistar rat embryos (Japan SLC, Inc.) were minced into fine pieces, rinsed with PBS, and incubated with 0.05% trypsin at 37°C (C) ATXN7 and -tubulin co-localize at the spindle during mitosis, although ATXN7 is much more broadly distributed in comparison to -tubulin.
(D) ATXN7 localization shifts to the nucleus, and in particular to chromatin-containing regions during anaphase.
(E) By telophase, ATXN7 appears mostly nuclear, though some ATXN7 staining persists in the cytoplasm after mitosis.
Full video images are shown in Supplementary Movies. by guest on November 4, 2016
